0.37 (1.77%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Weak
Balance Sheet
Very Strong
Website
ACADIA Pharmaceuticals Inc.
Telephone
1.858.558.2871
Address
Suite 400, 12830 El Camino Real, San Diego, CA 92130-3331
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 19.69 - 28.35
Trade Value (12mth)
US$10,425,370.00
1 week
-2.1%
1 month
-5.8%
YTD
-20.31%
1 year
-2.78%
All time high
58.72
EPS 3 yr Growth
-273.90%
EBITDA Margin
10.90%
Operating Cashflow
$110m
Free Cash Flow Return
10.80%
ROIC
38.30%
Interest Coverage
0.00
Quick Ratio
3.70
Shares Outstanding (Fully Diluted)
173m
HALO Sector
Healthcare
Next Company Report Date
01-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 01 May 26 | |
| 01 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.37 | 1.37 | 2.32 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.37 | 1.36 | 2.3 | | | | ||
Growth | % | | | | | 72 | 465.3 | 70 | | | | ||
PE | X | | | | | N/A | 13.5 | 11.6 | | | | ||
EV/EBITDA | X | | | | | N/A | 22.9 | 31.9 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
